Lataa...
Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol
Background: Dolutegravir (DTG; Tivicay; ViiV Healthcare, Research Triangle Park, NC) is an HIV-1-unboosted integrase inhibitor with no cytochrome P450 or uridine 5′diphosphate-glucuronosyltransferase inhibition or induction. As DTG is administered to HIV-1–infected women receiving oral contraceptive...
Tallennettuna:
| Julkaisussa: | Ann Pharmacother |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472613/ https://ncbi.nlm.nih.gov/pubmed/25862012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1060028015580637 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|